We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Published results showed patients with shoulder ...

Please provide your email address to receive an email when new articles are posted on . Durect Corporation has announced the FDA approval of Posimir, a post-surgical, non-opioid local analgesic for ...

POSIMIR ® (bupivacaine solution) for infiltration use reduced mean pain over 72 hours after arthroscopic subacromial decompression surgery compared with vehicle control and improved several measures ...

Arthroscopic subacromial decompression surgery does not reduce pain any more than arthroscopy alone in people with shoulder impingement, researchers say. "[T]he findings from our study suggest that ...

In patients with symptoms of shoulder impingement syndrome, is subacromial decompression surgery more effective than sham arthroscopy or exercise therapy to decrease pain and improve function? Finnish ...

Innocoll Pharmaceuticals Limited, a commercial-stage biotechnology company and portfolio business of Gurnet Point Capital, and DURECT Corporation announced the recent commercial launch of Posimir ...

Posimir is a novel formulation of bupivacaine, an amide local anesthetic, designed to be administered directly into the surgical site. Posimir ® (bupivacaine solution) is now available for ...

Posimir is a novel formulation of bupivacaine, an amide local anesthetic, designed to be administered directly into the surgical site. The Food and Drug Administration (FDA) has approved Posimir ® ...

The investigators enrolled 210 adults, aged 35 to 65 years, with a clinical presentation of shoulder impingement syndrome (without evidence of arthritis or rotator cuff tear on magnetic resonance ...

Research investigating a popular form of surgery aimed at easing chronic shoulder pain doesn't fix the problem, a careful, placebo-controlled study suggests. In the condition known as shoulder ...